SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice

BACKGROUND: Type 2 diabetes (T2D) is associated with generalized vascular dysfunction characterized by increases in large artery stiffness, endothelial dysfunction, and vascular smooth muscle dysfunction. Sodium glucose cotransporter 2 inhibitors (SGLT2i) represent the most recently approved class o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dustin M., Battson, Micah L., Jarrell, Dillon K., Hou, Shuofei, Ecton, Kayl E., Weir, Tiffany L., Gentile, Christopher L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921754/
https://www.ncbi.nlm.nih.gov/pubmed/29703207
http://dx.doi.org/10.1186/s12933-018-0708-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921754/
https://www.ncbi.nlm.nih.gov/pubmed/29703207
http://dx.doi.org/10.1186/s12933-018-0708-x

Ejemplares similares